ACLARION, INC. Fair Value, Net Asset (Liability)
ACLARION, INC. (ACON) had Fair Value, Net Asset (Liability) of $102 as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:FairValueNetAssetLiability · last filed 2025-11-12
- 2025-09-30: Fair Value, Net Asset (Liability) $102.00.
- 2025-06-30: Fair Value, Net Asset (Liability) $103.00.
- 2025-03-31: Fair Value, Net Asset (Liability) $148.00.
- 2024-12-31: Fair Value, Net Asset (Liability) $92.64K; Fair Value, Net Asset (Liability) as first filed $11.87K.
| Period end | Fair Value, Net Asset (Liability) | Fair Value, Net Asset (Liability) as first filed |
|---|---|---|
| 2025-09-30 | $102.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $103.00 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $148.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $92.64K 10-Q · filed 2025-11-12 | $11.87K 10-K · filed 2025-04-09 |
| 2024-09-30 | $16.27K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $42.46K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $67.82K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $410.49K 10-K · filed 2025-04-09 | |
| 2023-09-30 | $578.35K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $754.79K 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |